The Role of Complement Blockade in the Management of IgA Nephropathy
“The Role of Complement Blockade in the Management of IgA Nephropathy” published on 08 Apr 2024 by American Society of Nephrology.
“The Role of Complement Blockade in the Management of IgA Nephropathy” published on 08 Apr 2024 by American Society of Nephrology.
This week, we will discuss the second part of the 2024 CKD guidelines from KDIGO. Lots to chew on, so let’s dive in!
AJKDBlog Interviews Editor Timothy Yau (@Maximal_Change) caught up with Kueiyu Joshua Lin to discuss his study recently published in AJKD comparing the safety and effectiveness of…
This week, we will discuss the role of ApoE in determining the subtypes of C3 Glomerulopathy.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
The plasma proteome spans thousands of proteins whose levels are dynamic and vary by orders of magnitude, are diverse in origin, and play a wide…
is a limited number of studies of longitudinal metabolomics, and virtually none in pediatric CKD. Methods The Chronic Kidney Disease in Children (CKiD) study is…
Nature Reviews Nephrology – Primary aldosteronism is the most common cause of endocrine arterial hypertension and is characterized by the autonomous production of aldosterone from…
“Use of the Kidney Failure Risk Equation in Clinical Practice” published on 07 May 2024 by American Society of Nephrology.
a 24-item KRT knowledge instrument (Know-KRT) encompassing three domains of General, Technical, and Correlative information critical for informed dialysis decision-making. We conducted a cross-sectional study…
role in AKI remains unclear. Methods We explored the role of lncRNA Neat1 in (1) a cross-sectional and a longitudinal cohort of AKI in human;…